Comparative toxicity and safety profile of fenofibrate and other fibric acid derivatives
- 27 November 1987
- journal article
- clinical trial
- Published by Elsevier in American Journal Of Medicine
- Vol. 83 (5), 26-36
- https://doi.org/10.1016/0002-9343(87)90868-0
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Effect of short‐term treatment with bezafibrate and fenofibrate on biliary lipid metabolism in patients with hyperlipoproteinaemiaEuropean Journal of Clinical Investigation, 1984
- Relationship between morphological changes and lipid-lowering action of -chlorphenoxyisobutyric acid (CPIB) on hepatic mitochondria and peroxisomes in manAtherosclerosis, 1983
- Influence of fenofibrate on cellular and subcellular liver structure in hyperlipidemic patientsAtherosclerosis, 1983
- Light and electron microscopy of liver in hyperlipoproteinemic patients under long-term gemfibrozil treatmentAtherosclerosis, 1982
- THE SHORT‐ AND LONG‐TERM EFFECTS OF BEZAFIBRATE IN THE RAT*Annals of the New York Academy of Sciences, 1982
- Effects of -chlorophenoxyisobutyric acid (CPIB) on the human liverAtherosclerosis, 1980
- Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogensNature, 1980
- Uric acid: a risk factor for coronary heart disease?Circulation, 1979
- CLOFIBRATE AND THE LIVERThe Lancet, 1978
- Malignant Tumors in Rats Fed Nafenopin, a Hepatic Peroxisome Proliferator 2JNCI Journal of the National Cancer Institute, 1977